Yahoo
ASX - Delayed Quote AUD

Cochlear Limited (COH.AX)

143.64 +1.44 (+1.01%)
At close: October 30 at 4:10:11 PM GMT+11
Chart Range Bar
Loading chart for COH.AX
  • Previous Close 142.20
  • Open 141.02
  • Bid 142.99 x --
  • Ask 144.00 x --
  • Day's Range 140.01 - 145.14
  • 52 Week Range 88.74 - 291.20
  • Volume 275,834
  • Avg. Volume 591,809
  • Market Cap (intraday) 9.394B
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) 63.84
  • EPS (TTM) 2.25
  • Earnings Date Aug 18, 2026
  • Forward Dividend & Yield 2.60 (1.81%)
  • Ex-Dividend Date Sep 21, 2026
  • 1y Target Est 136.34

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

www.cochlear.com

5,400

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

COH.AX
43.65%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

COH.AX
48.85%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

COH.AX
37.24%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

COH.AX
29.51%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

110.00 Low
136.34 Average
143.64 Current
165.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.27%

  • Return on Assets (ttm)

    9.71%

  • Return on Equity (ttm)

    7.98%

  • Revenue (ttm)

    2.35B

  • Net Income Avi to Common (ttm)

    147.3M

  • Diluted EPS (ttm)

    2.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    187.7M

  • Total Debt/Equity (mrq)

    12.22%

  • Levered Free Cash Flow (ttm)

    313.59M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: